Sources | Names Used |
---|---|
CTRPv2 | sirolimus:bortezomib (250:1 mol/mol) |
PharmacoGx | sirolimus:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KCNN3 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
mRNA | ZNF407 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
mRNA | ARRB1 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-07 |
mRNA | ZBTB5 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
mRNA | UBE2G1 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
mRNA | KATNAL2 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
mRNA | E2F5 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |
mRNA | ANGEL2 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-07 |
mRNA | TCF3 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-07 |
mRNA | RAB30 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-07 |